StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly GAAP gross margin by Quarter

GAAP gross margin ($M) ($M)

QuarterlyAnnual

Eli Lilly GAAP gross margin: $19,706M in Q2 2026, up 50.3% from a year earlier. That is the highest of the 33 quarters on record here.

Latest, Q2 2026
19,706
Period ended Jun 30, 2026
Change on a year earlier
+50.3%
13,110 in Q2 2025
History
33 quarters
Since Q1 2017
Sources
29
Documents cited below

Where the Q2 2026 figure comes from

“|| Gross margin | $ | 19,706 | $ | 13,110 | 50 | $ | 35,928 | $ | 23,614 | 52”

Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K MD&A & Form 8-K Earnings Releases.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP gross margin ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202619,706+50.3%Form 10-Q FY2026Q2 (filed 2026-08-05) ↗
Q1 2026Mar 31, 202616,222+54.4%Form 10-Q FY2026Q1 (filed 2026-04-30) ↗
Q4 2025Dec 31, 202515,920+43.0%Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
Q3 2025Sep 30, 202514,593+57.4%Form 10-Q FY2025Q3 (filed 2025-10-30) ↗
Q2 2025Jun 30, 202513,110+43.6%Form 10-Q FY2025Q2 (filed 2025-08-07) ↗
Q1 2025Mar 31, 202510,504+48.1%Form 10-Q FY2025Q1 (filed 2025-05-01) ↗
Q4 2024Dec 31, 202411,129+47.1%Earnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
Q3 2024Sep 30, 20249,268+21.3%Form 10-Q FY2024Q3 (filed 2024-10-30) ↗
Q2 2024Jun 30, 20249,133+40.4%Form 10-Q FY2024Q2 (filed 2024-08-08) ↗
Q1 2024Mar 31, 20247,095+33.0%Form 10-Q FY2024Q1 (filed 2024-04-30) ↗
Q4 2023Dec 31, 20237,565+31.5%Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 20237,639+42.4%Form 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 20236,505+28.6%Form 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 20235,333-7.1%Form 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q4 2022Dec 31, 20225,754–Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2022Sep 30, 20225,363+0.4%Form 10-Q FY2022Q3 (filed 2022-11-01) ↗

Breakdown

What makes up GAAP gross margin

Cite this data

StockData. (2026). Eli Lilly GAAP gross margin ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/gm-gaap

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.